Connect Biopharma Holdings Ltd.

09/02/2021 | Press release | Distributed by Public on 09/02/2021 06:04

Connect Biopharma Announces First Patient Dosed in China Pivotal Trial Evaluating CBP-201 in Adults with Moderate-to-Severe Atopic Dermatitis